Dynavax Technologies | Passivo Circulante

Current Liabilities Alterar Data
Adma Biologics USD 49.81M 7.96M 2023-12
Amgen USD 18.39B 1.44B 2023-12
AstraZeneca USD 28.59B 2.21B 2023-09
Dynavax Technologies USD 62.2M 7.93M 2023-12
Gilead Sciences USD 11.28B 665M 2023-12
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Roche Holding CHF 26.21B 1.03B 2023-06
Vertex Pharmaceuticals USD 3.6B 247.3M 2023-09



Dynavax Technologies Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2024.